Guidance for 2025

Guidance for 2025

(unchanged)

Terveystalo clarified the structure of its guidance in connection with the half-year report and provided a range for adjusted EBIT in euros instead of revenue and adjusted EBIT margin.

Terveystalo expects its full-year 2025  adjusted EBIT to be EUR 155-165 million (2024: EUR 140.5 million).

The estimates are based on the current demand environment, employment levels, and morbidity rates. The estimates account for a decrease of approximately EUR 30 million in revenue within the Portfolio Businesses segment's outsourcing operations due to the ending of contracts. Profitability is expected to strengthen in all business segments. The estimates do not account for significant acquisitions or divestments.